Xenetic Biosciences financial statements
제네틱 바이오사이언시스NASDAQ:XBIO · Nasdaq · Healthcare$2.21+4.25%
2026-10-07 close · prelimXenetic Biosciences's published financial data is dated 2026-10-04. 2024 revenue was $3M. 2024 operating profit was −$4M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy